文献速递脑血管病神经重症与神经感染

静脉降压药与成功取栓后功能结局的关联

Association Between Intravenous Antihypertensives and Functional Outcome After Successful Endovascular Thrombectomy.
PubMed 文献 · Stroke · 2025-07-03

该研究为OPTIMAL-BP试验的探索性二次分析,纳入302例成功再通患者,比较24小时内是否使用静脉降压药与3个月功能独立的关系。结果显示使用静脉降压药与3个月功能独立率更低、24小时神经恢复更差及卒中相关死亡率更高相关,症状性颅内出血无显著差异。

要点

  • 成功取栓后24小时内使用静脉降压药与3个月功能独立率更低相关(aOR 0.51)。
  • 静脉降压药组卒中相关死亡率更高(aOR 4.21),症状性颅内出血无显著差异。
  • 取栓成功后立即静脉降压需谨慎评估风险与获益。

核心结论

  • 成功取栓后24小时内使用静脉降压药与3个月功能结局更差相关。

研究设计与样本

  • OPTIMAL-BP试验的探索性二次分析,纳入韩国19家卒中中心302例成功再通患者。

主要发现

  • 141例(46.7%)在取栓后24小时内接受静脉降压药,其中133例(94.3%)使用尼卡地平。
  • 静脉降压药组3个月功能独立率更低(aOR 0.51,95%CI 0.27-0.95,P=0.035)。
  • 静脉降压药组24小时良好神经恢复率更低(aOR 0.46,95%CI 0.22-0.94,P=0.036)。
  • 静脉降压药组卒中相关死亡率更高(aOR 4.21,95%CI 1.24-16.4,P=0.027)。
  • 两组症状性颅内出血无显著差异(aOR 1.67,95%CI 0.68-4.19,P=0.267)。

临床怎么用

  • 取栓成功后24小时内启动静脉降压药前应谨慎权衡功能获益与死亡风险。

局限性

  • 为探索性二次分析,非随机分组,可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intravenous antihypertensives are frequently used to control blood pressure after successful endovascular thrombectomy (EVT), yet studies investigating the relationship between intravenous antihypertensive use and functional outcomes after successful EVT remain limited. METHODS: We conducted an exploratory secondary analysis of the OPTIMAL-BP trial (Outcome in Patients Treated With Intra-Arterial Thrombectomy-Optimal Blood Pressure Control), which compared intensive (systolic blood pressure <140 mm Hg) versus conventional blood pressure management (systolic blood pressure, 140-180 mm Hg) within the first 24 hours after successful recanalization across 19 stroke centers in South Korea between June 2020 and November 2022. Patients were classified according to the administration of intravenous antihypertensives within the initial 24 hours after enrollment. The primary efficacy outcome was functional independence (modified Rankin Scale score of 0-2) at 3 months. RESULTS: Of the 302 patients (median, 75 years; 180 [59.6%] men), 141 (46.7%) received intravenous antihypertensives within the first 24 hours after EVT. Among the 141 patients who received intravenous antihypertensives, 133 (94.3%) were treated with nicardipine, 10 (7.0%) received labetalol, and 2 (1.4%) were administered both drugs. Patients who received intravenous antihypertensives had significantly lower rates of functional independence at 3 months (adjusted odds ratio, 0.51 [95% CI, 0.27-0.95]; P=0.035) and excellent neurological recovery at 24 hours (adjusted odds ratio, 0.46 [95% CI, 0.22-0.94]; P=0.036), as well as higher stroke-related mortality rates (adjusted odds ratio, 4.21 [95% CI, 1.24-16.4]; P=0.027), compared with patients who did not receive intravenous antihypertensives. Symptomatic intracerebral hemorrhage was not significantly different between groups (adjusted odds ratio, 1.67 [95% CI, 0.68-4.19]; P=0.267). CONCLUSIONS: The use of intravenous antihypertensives within the first 24 hours after successful EVT was associated with worse functional outcomes at 3 months. This finding highlights the need for a cautious assessment of the risks and benefits of administering intravenous antihypertensives immediately after EVT. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04205305.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Jung JW, Kim YD, Heo J, et al. Association Between Intravenous Antihypertensives and Functional Outcome After Successful Endovascular Thrombectomy. Stroke. 2025. PMID: 40605757. doi:10.1161/STROKEAHA.125.051696

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。